Amedisys Inc

Amedisys — Q1 2024 Earnings Presentation

16 slides from Amedisys's earnings presentation, Apr 24, 2024

  1. Slide 1: Amedisys First Quarter 2024 Earnings Release Supplemental Slides

    1 Amedisys First Quarter 2024 Earnings Release Supplemental Slides April 24th, 2024 Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    2 This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could c

  3. Slide 3: Our Key Areas of Focus

    3 OUR KEY AREAS OF FOCUS Strategic areas of focus and progress made during Q1’24 • Home Health: Total same store admissions +10% • Hospice: Total same store ADC flat • High Acuity Care: Admissions +23% 1 Organic Growth • Quality: Amedisys Jul’24 preview STARS score of 4.32 • 92% of care centers at 4

  4. Slide 4: Highlights and Summary Financial Results (Adjusted): 1Q 24

    4 HIGHLIGHTS AND SUMMARY FINANCIAL RESULTS (ADJUSTED): 1Q 2024(1) Excluding the results from our personal care segment (sold March 31, 2023), EBITDA increased $4 million over prior year on a $30 million increase in revenue. Our results were impacted by rate increases, home health volume growth, impr

  5. Slide 5: Revenue Mix and Reimbursement by Segment

    5 59.3% 11.9% 28.8% Home Health Revenue Medicare FFS Private Episodic Per Visit & Case Rate 63.7% 35.2% 1.1% Amedisys Consolidated Revenue Home Health Hospice High Acuity Care • Medicare FFS: Reimbursed for a 30-day period of care • Private Episodic: MA and Commercial plans who reimburse us for a 30

  6. Slide 6: Home Health and Hospice Segment (Adjusted) – Q1 2024

    6 HOME HEALTH AND HOSPICE SEGMENT (ADJUSTED) – Q1 2024(1) • Medicare revenue per episode up 0.8% primarily due to the rate increase effective 1/1/2024. • Y/Y Total CPV up $6.19 (+5.6%) primarily due to raises, wage inflation and an increase in new hire pay. A reduction in VPE on our episodic revenue

  7. Slide 7: General & Administrative Expenses – Adjusted

    7 GENERAL & ADMINISTRATIVE EXPENSES – ADJUSTED (1,2) Notes: • Year over year total G&A as a percentage of revenue increased 10 basis points ($6 million) • Increase in total G&A is primarily due to planned wage increases and higher incentive compensation costs partially offset by the divestiture of o

  8. Slide 8: Operational Excellence: Home Health Cost Per Visit (CPV)-Adjusted

    8 $25.00 $50.00 $75.00 $100.00 $125.00 1Q23 4Q23 1Q24 Cost Per Visit (CPV) Salaries Contractors Benefits Transportation OPERATIONAL EXCELLENCE: HOME HEALTH COST PER VISIT (CPV)-ADJUSTED YOY Total CPV impacted by higher labor costs. *Note: Direct comparison with industry competitors CPV calculation $

  9. Slide 9: Driving Top Line Growth

    9 DRIVING TOP LINE GROWTH 5% 3% 3% 5% 8% 8% 4% 4% 7% 10% 0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% 100,000 120,000 140,000 160,000 1Q23 2Q23 3Q23 4Q23 1Q24 Volume SS Volume Growth SS Admit Growth Home Health Growth Hospice Growth -1% -2% -2% -0.2% 0.3% -2.5% -1.5% -0.5% 0.5% 12,500 12,750 13,000 1Q23 2Q2

  10. Slide 10: Industry Leading Quality Scores

    10 INDUSTRY LEADING QUALITY SCORES Quality of Patient Care (QPC) Patient Satisfaction (PS) • Amedisys maintains a 4-Star average in the Jul 2024 HHC Preview with 93% of our providers (representing 92% of care centers) at 4+ Stars and 59% of our providers (representing 61% of care centers) at 4.5+ St

  11. Slide 11: Hospice Quality: Moving Towards Best-in-Class

    11 HOSPICE QUALITY: AMEDISYS HOSPICE CONTINUES TO MOVE TOWARDS BEST-IN-CLASS Hospice Quality Notes: Included in the above analysis are only active providers. Exhibit 99.2

  12. Slide 12: Debt and Liquidity Metrics

    12 DEBT AND LIQUIDITY METRICS Net leverage ~1.2x 1. Net debt defined as total debt outstanding ($395.6M) less cash and cash equivalents ($108.2M). 2. Leverage ratio (net) is defined as net debt divided by last twelve months adjusted EBITDA ($249.0M). 3. Liquidity defined as the sum of cash balance a

  13. Slide 13: Cash Flow Statement Highlights

    13 CASH FLOW STATEMENT HIGHLIGHTS (1) Total cash flow from operations for Q1-24 impacted by delays in the billing and collection of accounts receivable resulting from the Change Healthcare outage partially offset by the timing of the payment of accounts payable. 1. Free cash flow defined as cash flo

  14. Slide 14: Income Statement Adjustments

    14 INCOME STATEMENT ADJUSTMENTS (1) 1. The financial results for the three-month periods ended March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024 are adjusted for certain items and should be considered a non-GAAP financial measure. A reconciliation of these non-G

  15. Slide 15: Environmental, Social, Governance (E.S.G.) Considerations

    15 Environmental, Social, Governance (E.S.G.) Considerations Exhibit 99.2

  16. Slide 16: Environmental, Social, Governance (E.S.G.) Considerations

    16 ENVIRONMENTAL, SOCIAL, GOVERNANCE (E.S.G.) CONSIDERATIONS Sustainable, high-quality, patient focused, home-based care model E n vi ro nmental, Social, Govern an ce Environmental • Amedisys is dedicated to the sustainability of our business and the communities in which we serve • Environmental hea

Amedisys — Q1 2024 Earnings Presentation on 6ix